Canandaigua National Bank & Trust’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.92M | Buy |
+10,817
| New | +$3.7M | 0.33% | 62 |
|
|
2025
Q4 | $3.6M | Sell |
10,999
-472
| -4% | -$150K | 0.32% | 64 |
|
|
2025
Q3 | $3.24M | Sell |
11,471
-759
| -6% | -$220K | 0.28% | 76 |
|
|
2025
Q2 | $3.41M | Sell |
12,230
-395
| -3% | -$112K | 0.32% | 71 |
|
|
2025
Q1 | $3.93M | Sell |
12,625
-6
| -0% | -$1.77K | 0.39% | 56 |
|
|
2024
Q4 | $3.29M | Sell |
12,631
-276
| -2% | -$81.9K | 0.32% | 73 |
|
|
2024
Q3 | $4.16M | Buy |
12,907
+125
| +1% | +$40.9K | 0.4% | 58 |
|
|
2024
Q2 | $3.99M | Sell |
12,782
-121
| -0.9% | -$35.5K | 0.43% | 54 |
|
|
2024
Q1 | $3.67M | Sell |
12,903
-104
| -0.8% | -$30.4K | 0.54% | 49 |
|
|
2023
Q4 | $3.75M | Sell |
13,007
-333
| -2% | -$90.7K | 0.58% | 45 |
|
|
2023
Q3 | $3.59M | Sell |
13,340
-124
| -0.9% | -$30.9K | 0.58% | 47 |
|
|
2023
Q2 | $2.99M | Buy |
13,464
+393
| +3% | +$91.2K | 0.48% | 59 |
|
|
2023
Q1 | $3.16M | Buy |
+13,071
| New | +$3.21M | 0.53% | 50 |
|
|
2020
Q1 | $2.61M | Buy |
12,895
+503
| +4% | +$110K | 0.55% | 53 |
|
|
2019
Q4 | $2.99M | Sell |
12,392
-97
| -0.8% | -$21.4K | 0.5% | 59 |
|
|
2019
Q3 | $2.42M | Buy |
12,489
+2,577
| +26% | +$495K | 0.43% | 67 |
|
|
2019
Q2 | $1.83M | Buy |
9,912
+8
| +0.1% | +$1.43K | 0.34% | 87 |
|
|
2019
Q1 | $1.88M | Buy |
9,904
+239
| +2% | +$45.6K | 0.36% | 75 |
|
|
2018
Q4 | $1.88M | Buy |
9,665
+536
| +6% | +$105K | 0.4% | 71 |
|
|
2018
Q3 | $1.89M | Buy |
9,129
+989
| +12% | +$195K | 0.34% | 88 |
|
|
2018
Q2 | $1.5M | Buy |
8,140
+17
| +0.2% | +$3.01K | 0.29% | 96 |
|
|
2018
Q1 | $1.39M | Buy |
8,123
+620
| +8% | +$114K | 0.18% | 137 |
|
|
2017
Q4 | $1.3M | Sell |
7,503
-120
| -2% | -$21.2K | 0.24% | 107 |
|
|
2017
Q3 | $1.42M | Buy |
7,623
+201
| +3% | +$35.6K | 0.27% | 96 |
|
|
2017
Q2 | $1.28M | Sell |
7,422
-342
| -4% | -$55.6K | 0.26% | 100 |
|
|
2017
Q1 | $1.27M | Sell |
7,764
-95
| -1% | -$15.8K | 0.38% | 75 |
|
|
2016
Q4 | $1.15M | Buy |
7,859
+515
| +7% | +$77.5K | 0.34% | 83 |
|
|
2016
Q3 | $1.23M | Buy |
7,344
+125
| +2% | +$21.1K | 0.35% | 78 |
|
|
2016
Q2 | $1.1M | Buy |
7,219
+84
| +1% | +$13.1K | 0.31% | 88 |
|
|
2016
Q1 | $1.07M | Buy |
7,135
+695
| +11% | +$103K | 0.31% | 85 |
|
|
2015
Q4 | $1.04M | Sell |
6,440
-201
| -3% | -$31.6K | 0.32% | 82 |
|
|
2015
Q3 | $919K | Buy |
6,641
+683
| +11% | +$108K | 0.29% | 87 |
|
|
2015
Q2 | $915K | Buy |
5,958
+500
| +9% | +$80.1K | 0.27% | 93 |
|
|
2015
Q1 | $872K | Buy |
5,458
+85
| +2% | +$13.4K | 0.26% | 95 |
|
|
2014
Q4 | $856K | Sell |
5,373
-50
| -0.9% | -$7.79K | 0.27% | 89 |
|
|
2014
Q3 | $762K | Buy |
5,423
+311
| +6% | +$40.6K | 0.25% | 88 |
|
|
2014
Q2 | $605K | Hold |
5,112
| – | – | 0.2% | 106 |
|
|
2014
Q1 | $631K | Sell |
5,112
-300
| -6% | -$36.4K | 0.21% | 100 |
|
|
2013
Q4 | $617K | Sell |
5,412
-100
| -2% | -$11.4K | 0.22% | 96 |
|
|
2013
Q3 | $617K | Buy |
5,512
+300
| +6% | +$32.5K | 0.23% | 94 |
|
|
2013
Q2 | $514K | Buy |
+5,212
| New | +$541K | 0.2% | 103 |
|
Other funds holding AMGN
Canandaigua National Bank & Trust's AMGN Position: Q2 2026 in Review
Canandaigua National Bank & Trust opened a new position in Amgen (AMGN) in Q2 2026: 10,817 shares worth $3.92M. The stake represents 0.33% of the portfolio and ranks #62 among its holdings. This is a return to the name: Canandaigua National Bank & Trust previously reported a position in AMGN as recently as Q4 2025.
Canandaigua National Bank & Trust first reported a position in AMGN in Q2 2013 and has held it in 41 quarters since. The position peaked at $4.16M in Q3 2024. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Canandaigua National Bank & Trust held 10,817 shares of Amgen worth $3.92M as of Q2 2026.
- Amgen was a new Canandaigua National Bank & Trust position in Q2 2026.
- Amgen made up 0.33% of Canandaigua National Bank & Trust's portfolio in Q2 2026, its #62 holding.
- Canandaigua National Bank & Trust first reported a position in Amgen in Q2 2013 and has held it in 41 quarters since.
- Canandaigua National Bank & Trust's Amgen position peaked at $4.16M in Q3 2024.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Canandaigua National Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.